What we are studying
The purpose of this study is to see if benralizumab, given as injections under the skin for once every 4 weeks or once every 8 weeks, for a total of 24 weeks, can reduce the dose of your oral corticosteroids and help control your asthma better if it is added to currently available asthma medications (eg anti-inflammatory inhaled steroid also referred to as inhaled corticosteroids (ICS) and a long lasting airway opener also referred to as long acting ß-agonists (LABA)). This study will explore whether benralizumab helps to reduce oral corticosteroids dependence, how often benralizumab needs to be given, who responds best to benralizumab, and how well benralizumab is tolerated. This study will measure levels of benralizumab in the blood and see how the body accepts the study drug.
You will be paid $800.00 if you complete all the scheduled study visits. If you withdraw for any reason from the study before completion you will be paid $50.00 for each complete study visit.